Quantcast

Latest Transplantation medicine Stories

2014-01-28 09:29:14

Temple researchers find equivalent outcomes for double-lung transplants when blood type between donor and recipient is identical or compatible In the largest retrospective study to date using data from the United Network for Organ Sharing (UNOS) database for adult double-lung transplants, Temple University School of Medicine researchers have shown that there is no statistically significant difference between rejection and mortality rates among double-lung transplant recipients when their...

2014-01-17 23:00:49

Regenerative medicine company builds strong leadership team for future growth. Los Angeles, CA (PRWEB) January 17, 2014 PlasmaGenix, Inc. (Inglewood, CA) is pleased to appoint James Hays as the company’s President and CEO. PlasmaGenix develops regenerative therapeutics derived from the patient’s endogenous blood and tissues. Mr. Hays brings with him +20 years of experience in tissue banking and regenerative medicine, and has been instrumental in launching national sales programs...

2014-01-16 16:24:21

DUBLIN, January 16, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/ql5c3g/orthobiologics) has announced the addition of the "Orthobiologics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" [http://www.researchandmarkets.com/research/ql5c3g/orthobiologics ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Orthobiology is a branch of science that...

2014-01-16 12:29:30

LONDON, Jan. 16, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: UK Orthopedic Biomaterial Market Forecast To 2018 Short Description This research report provides key market trends, market forecasts and competitive scenario of the orthopedic biomaterial in the UK through 2018. The product categories covered in this report include: -- Bone Allografts-- Demineralized Bone Material (DBM)-- Bone Graft Substitutes-- Bone Growth Stimulators--...

2014-01-15 08:28:54

LONDON, Jan. 15, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:US Dental Biomaterial Market Trends Forecast Through 2018 Short DescriptionThis research report provides key market trends, market forecasts and competitive scenario of the dental biomaterial in the US through 2018.The product categories covered in this report include: -- Dental Bone Graft Substitutes-- Dental Bone Grafts-- Tissue Regenerative Materials ScopeThe report highlights...

2014-01-14 16:25:25

LONDON, Jan. 14, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: US Orthopedic Biomaterial Market Outlook and Trends Till 2018 Short Description This research report provides key market trends, market forecasts and competitive scenario of the orthopedic biomaterial in the US through 2018. The product categories covered in this report include: -- Bone Allografts-- Demineralized Bone Material (DBM)-- Bone Graft Substitutes-- Bone Growth...

2014-01-13 12:28:13

LONDON, Jan. 13, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: India Orthopedic Biomaterial Market Forecast To 2018 Short Description This research report provides key market trends, market forecasts and competitive scenario of the orthopedic biomaterial in India through 2018. The product categories covered in this report include: -- Bone Allografts-- Demineralized Bone Material (DBM)-- Bone Graft Substitutes-- Bone Growth Stimulators--...

2014-01-13 12:28:11

LONDON, Jan. 13, 2014 /PRNewswire/ -- UK-ReportbuyerReportbuyer.com just published a new market research report: China Orthopedic Biomaterial Market Forecast To 2018 Short DescriptionThis research report provides key market trends, market forecasts and competitive scenario of the orthopedic biomaterial in China through 2018.The product categories covered in this report include: -- Bone Allografts-- Demineralized Bone Material (DBM)-- Bone Graft Substitutes-- Bone Growth...

2014-01-13 08:26:47

Phase 1 Trial of BL-8040 expected to begin in Q2 2014; top-line results expected in H2 2014 JERUSALEM, Jan. 13, 2014 /PRNewswire/ -- BioLineRx (NASDAQ: BLRX; TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it has filed the necessary regulatory submissions to commence a Phase 1 trial for BL-8040, a novel treatment for the mobilization of stem cells from the bone...

2014-01-08 12:30:01

HORSHOLM, Denmark, Jan. 8, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO), today announced that United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 13/167,420, a patent which covers the diurnal-independent administration of Envarsus(®). The subject patent covers a method of administering Envarsus(®), Veloxis' once-daily formulation of tacrolimus employing the company's proprietary MeltDose(®)...


Latest Transplantation medicine Reference Libraries

Bone Marrow Transplantation (journal)
2012-06-04 20:00:41

Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...

More Articles (1 articles) »
Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related